Sign in

CIK 0001840229

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

MiNK Therapeutics, Inc.

Sign in to watch
Ticker
INKT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 212-994-8250
Business address
149 FIFTH AVENUE, SUITE 500, NEW YORK, NY, 10010
Former names
AgenTus Therapeutics, Inc., AgenTus Therapeutics, Inc.
  1. 4 Grant or award Director acquired 1,173 shares (grant or award)
  2. 4 Grant or award Director acquired 2,494 shares (grant or award)
  3. 4 Grant or award Director acquired 2,267 shares (grant or award)
  4. 4 Grant or award Director acquired 1,883 shares (grant or award)
  5. 4 Grant or award Director acquired 1,953 shares (grant or award)
  6. 4 Grant or award Director acquired 2,476 shares (grant or award)
  7. 4 Grant or award Director acquired 1,536 shares (grant or award)
  8. 4 Grant or award Director acquired 1,849 shares (grant or award)
  9. 4 Grant or award Director acquired 1,593 shares (grant or award)
  10. 4 Grant or award Director acquired 2,019 shares (grant or award)
  11. 4 Grant or award Director acquired 2,033 shares (grant or award)
  12. 4 Grant or award Director acquired 12,286 shares (grant or award)
  13. 3 Insider Initial Statement of Ownership
  14. 4 Grant or award Director acquired 24,229 shares (grant or award)
  15. 4 Grant or award Director acquired 24,400 shares (grant or award)
  16. 4 Grant or award Director acquired 20,987 shares (grant or award)
  17. 4 Grant or award Director acquired 20,476 shares (grant or award)
  18. 4 Grant or award Director acquired 21,649 shares (grant or award)
  19. 4 Grant or award Director acquired 18,753 shares (grant or award)
  20. 4 Grant or award Director acquired 18,295 shares (grant or award)

Page 3 of 8 · 145 filings